Limitations, agreements, and source contact

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) · Source last updated 2021-07-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

takumi@canbas.co.jp

organization

CanBas Co., Ltd.

phone

81559543666

title

Takumi Kawabe, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice